BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34922473)

  • 1. Mammography screening and mortality by risk status in the California teachers study.
    Park HL; Chang J; Haridass V; Wang SS; Ziogas A; Anton-Culver H
    BMC Cancer; 2021 Dec; 21(1):1341. PubMed ID: 34922473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
    Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
    J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of recommendations for screening mammography using CISNET models.
    Arleo EK; Hendrick RE; Helvie MA; Sickles EA
    Cancer; 2017 Oct; 123(19):3673-3680. PubMed ID: 28832983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.
    Gao Y; Albert M; Young Lin LL; Lewin AA; Babb JS; Heller SL; Moy L
    Radiology; 2018 May; 287(2):423-431. PubMed ID: 29378151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
    Canelo-Aybar C; Posso M; Montero N; Solà I; Saz-Parkinson Z; Duffy SW; Follmann M; Gräwingholt A; Giorgi Rossi P; Alonso-Coello P
    Br J Cancer; 2022 Mar; 126(4):673-688. PubMed ID: 34837076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
    O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
    Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of modelling mammography screening strategies.
    Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
    Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening.
    Quante AS; Hüsing A; Chang-Claude J; Kiechle M; Kaaks R; Pfeiffer RM
    Cancer Prev Res (Phila); 2021 Jun; 14(6):627-634. PubMed ID: 34162683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
    Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
    JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
    Morrell S; Taylor R; Roder D; Dobson A
    J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
    Moorman SEH; Pujara AC; Sakala MD; Neal CH; Maturen KE; Swartz L; Egloff H; Helvie MA
    AJR Am J Roentgenol; 2021 Jul; 217(1):40-47. PubMed ID: 33955776
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
    Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
    Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
    Oeffinger KC; Fontham ET; Etzioni R; Herzig A; Michaelson JS; Shih YC; Walter LC; Church TR; Flowers CR; LaMonte SJ; Wolf AM; DeSantis C; Lortet-Tieulent J; Andrews K; Manassaram-Baptiste D; Saslow D; Smith RA; Brawley OW; Wender R;
    JAMA; 2015 Oct; 314(15):1599-614. PubMed ID: 26501536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.
    Wernli KJ; Arao RF; Hubbard RA; Sprague BL; Alford-Teaster J; Haas JS; Henderson L; Hill D; Lee CI; Tosteson ANA; Onega T
    J Womens Health (Larchmt); 2017 Aug; 26(8):820-827. PubMed ID: 28177856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Breast Density Implications and Breast Cancer Screening.
    Lian J; Li K
    Clin Breast Cancer; 2020 Aug; 20(4):283-290. PubMed ID: 32334975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography Screening Among the Elderly: A Research Challenge.
    Sanderson M; Levine RS; Fadden MK; Kilbourne B; Pisu M; Cain V; Husaini BA; Langston M; Gittner L; Zoorob R; Rust GS; Hennekens CH
    Am J Med; 2015 Dec; 128(12):1362.e7-14. PubMed ID: 26169884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.